London Daily

Focus on the big picture.
Tuesday, Jul 15, 2025

Pandemic-hit NHS wastes over £560mn yearly on ‘unnecessary’ & addictive pills with severe withdrawal symptoms – study

Pandemic-hit NHS wastes over £560mn yearly on ‘unnecessary’ & addictive pills with severe withdrawal symptoms – study

Despite the Covid pandemic, the NHS is reportedly wasting as much as £568 million yearly on habit-forming drugs like painkillers and sleeping pills that the majority of patients do not need, leading to dangerous addictions.

Doctors in England are unnecessarily pushing dependency-causing opioids, antidepressants and other pills, according to a new study by the Council for Evidence-based Psychiatry (CEP). Researchers found that three in four prescriptions were totally unnecessary in some cases.

The study, published on Tuesday in the journal Addictive Behaviours, revealed that, for many patients, their symptoms were not severe enough to warrant such medication. In other cases, safer options of treatment, such as counselling or less toxic drugs, were not fully explored while there were also instances of patients who were put on the pills for longer than required.

“Money is being wasted at a time when the health service is strapped for cash. The NHS is not taking this problem seriously and many doctors don’t appreciate the extent to which withdrawal from these medicines is a problem,” Dr James Davies, the study’s co-lead author, told the Daily Mail.


Between 2015 and 2018, the study estimated, there was a taxpayer bill of £1.7 billion for prescriptions for antidepressants, opioids, gabapentinoids, benzodiazepines and Z-drugs (sleeping pills). The total costs accounted for the price of the drugs, the average consultation cost (about £33) of seeing a General Practitioner (GP), and dispensing fees.

NHS figures reportedly show that nearly 17 million people a year in the country are getting a prescription for such drugs. The level of waste is so colossal that it could go towards paying the salaries of another 10,000 GPs or 20,000 nurses, according to the Daily Mail, which reported that the Department of Health and Social Care is yet to finalise plans to tackle the issue.

Nearly half the taxpayer money being wasted each year – to the tune of £288 million – goes towards highly addictive opioid painkillers followed by £158 million a year for gabapentinoids. But the researchers, from Roehampton University, Greenwich University and University College London, warn that it is likely the total amount lost is far higher than the “conservative” estimates in the study.

In addition, the study does not account for the significant costs related to harms caused by habit-forming drugs. These include higher disability payments and lost tax revenues, as well as workplace absenteeism and decreased productivity.

Besides the financial losses, unnecessary prescription also exacts a human cost: when people try to kick the habit, they suffer severe withdrawal symptoms, including stomach cramps, blurred vision and loss of appetite. For instance, studies on benzodiazepine usage reportedly show that 50% of those on the drugs for as little as four weeks suffer anxiety, dizziness, concentration problems, nightmares and weakness. That figure rises to 100% for people taking the medication for over six months.

Commenting on the study, Tory MP Danny Kruger, who chairs the All Party Parliamentary Group for Prescribed Drug Dependence, said that a “fraction of these wasted costs should now be invested in a helpline and dedicated withdrawal support services.”

In 2019, a Public Health England report revealed that “hundreds of thousands” of patients had become dependent on medicines and recommended face-to-face support, better training for doctors on the risks of drug dependency, and a 24-hour helpline on how to reduce medication.

While little action has occurred since, a Department of Health and Social Care spokesman told the Daily Mail that ministers are finally backing plans for a helpline and will be “working closely” with the NHS to implement the recommendations.

Newsletter

Related Articles

0:00
0:00
Close
Dimon Warns on Fed Independence as Trump Administration Eyes Powell’s Succession
Church of England Removes 1991 Sexuality Guidelines from Clergy Selection
Superman Franchise Achieves Success with Latest Release
Hungary's Viktor Orban Rejects Agreements on Illegal Migration
Jeff Bezos Considers Purchasing Condé Nast as a Wedding Gift
Ghislaine Maxwell Says She’s Ready to Testify Before Congress on Epstein’s Criminal Empire
Bal des Pompiers: A Celebration of Community and Firefighter Culture in France
FBI Chief Kash Patel Denies Resignation Speculations Amid Epstein List Controversy
Air India Pilot’s Mental Health Records Under Scrutiny
Google Secures Windsurf AI Coding Team in $2.4 Billion Licence Deal
Jamie Dimon Warns Europe Is Losing Global Competitiveness and Flags Market Complacency
South African Police Minister Suspended Amid Organised Crime Allegations
Nvidia CEO Claims Chinese Military Reluctance to Use US AI Technology
Hong Kong Advances Digital Asset Strategy to Address Economic Challenges
Australia Rules Out Pre‑commitment of Troops, Reinforces Defence Posture Amid US‑China Tensions
Martha Wells Says Humanity Still Far from True Artificial Intelligence
Nvidia Becomes World’s First Four‑Trillion‑Dollar Company Amid AI Boom
U.S. Resumes Deportations to Third Countries After Supreme Court Ruling
Excavation Begins at Site of Mass Grave for Children at Former Irish Institution
Iranian President Reportedly Injured During Israeli Strike on Secret Facility
EU Delays Retaliatory Tariffs Amid New U.S. Threats on Imports
Trump Defends Attorney General Pam Bondi Amid Epstein Memo Backlash
Renault Shares Drop as CEO Luca de Meo Announces Departure Amid Reports of Move to Kering
Senior Aides for King Charles and Prince Harry Hold Secret Peace Summit
Anti‑Semitism ‘Normalised’ in Middle‑Class Britain, Says Commission Co‑Chair
King Charles Meets David Beckham at Chelsea Flower Show
If the Department is Really About Justice: Ghislaine Maxwell Should Be Freed Now
NYC Candidate Zohran Mamdani’s ‘Antifada’ Remarks Spark National Debate on Political Language and Economic Policy
President Trump Visits Flood-Ravaged Texas, Praises Community Strength and First Responders
From Mystery to Meltdown, Crisis Within the Trump Administration: Epstein Files Ignite A Deepening Rift at the Highest Levels of Government Reveals Chaos, Leaks, and Growing MAGA Backlash
Trump Slams Putin Over War Death Toll, Teases Major Russia Announcement
Reparations argument crushed
Rainmaker CEO Says Cloud Seeding Paused Before Deadly Texas Floods
A 92-year-old woman, who felt she doesn't belong in a nursing home, escaped the death-camp by climbing a gate nearly 8 ft tall
French Journalist Acquitted in Controversial Case Involving Brigitte Macron
Elon Musk’s xAI Targets $200 Billion Valuation in New Fundraising Round
Kraft Heinz Considers Splitting Off Grocery Division Amid Strategic Review
Trump Proposes Supplying Arms to Ukraine Through NATO Allies
EU Proposes New Tax on Large Companies to Boost Budget
Trump Imposes 35% Tariffs on Canadian Imports Amid Trade Tensions
Junior Doctors in the UK Prepare for Five-Day Strike Over Pay Disputes
US Opens First Rare Earth Mine in Over 70 Years in Wyoming
Kurdistan Workers Party Takes Symbolic Step Towards Peace in Northern Iraq
Bitcoin Reaches New Milestone of $116,000
Biden’s Doctor Pleads the Fifth to Avoid Self-Incrimination on President’s Medical Fitness
Grok Chatbot Faces International Backlash for Antisemitic Content
Severe Heatwave Claims 2,300 Lives Across Europe
NVIDIA Achieves Historic Milestone as First Company Valued at $4 Trillion
Declining Beer Consumption Signals Cultural Shift in Germany
Linda Yaccarino Steps Down as CEO of X After Two Years
×